Mainstream

Actimed Therapeutics Appoints Dr Fabio Dorigotti As Chief Medical Officer To Drive Further Pipeline Development For Cancer Cachexia And Other Muscle Wasting Disorders

Actimed Therapeutics appoints Dr Fabio Dorigotti as Chief Medical Officer to drive further pipeline development for cancer cachexia and other muscle wasting disorders

Actimed Therapeutics appoints Dr Fabio Dorigotti as Chief Medical Officer to drive further pipeline development for cancer cachexia and other muscle wasting disorders

Fabio Dorigotti brings over 25 years of clinical development experienceJoins Actimed following retirement of Frank Misselwitz London,…Read More

You might also be interested in reading Finseta Beats Estimates with £11.3 Million Revenue in 2024.

January 16, 2025
In Mainstream